Form 483

Genzyme Corporation Form 483, 2016-08-18

FDA issued a Form 483 to Genzyme Corporation on 2016-08-18 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Genzyme Corporation · Northborough, United States · Issued August 18, 2016

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Aug 2016
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Arie Menachem

18 Aug 2016
21 CFR 211.192

No written record of investigation

Cited by Arie Menachem

18 Aug 2016
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Arie Menachem

Inspected site

GCGenzyme CorporationNorthborough, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere